USCAP 2023 Contemporary Issues in Breast Pathology

USCAP 2023 Contemporary Issues in Breast Pathology

156 $

Format : 22 MP4 + 18 PDF files

File Size : 55.39 GB

Category:

USCAP 2023 Contemporary Issues in Breast Pathology

This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized. This course includes a combination of lectures, interactive microscopy sessions, and a panel Q&A.

Are you a clinician, pathologist, or researcher looking to enhance your understanding of contemporary issues in breast pathology? Look no further! We are thrilled to present our comprehensive course on the pathologic diagnosis and clinical significance of breast lesions. This course provides a detailed review and update on the identification and classification of benign, in situ, and malignant breast lesions, as well as the latest immunohistochemical and molecular studies to aid in diagnosis and patient management.

With a combination of lectures, interactive microscopy sessions, and panel Q&A discussions, this course offers a dynamic and engaging learning experience. Our expert faculty will guide you through the diagnostic criteria and clinical significance of various breast lesions encountered in surgical specimens and core needle biopsies. You will also delve into differential diagnostic challenges in breast pathology and gain insights into the utility and limitations of ancillary immunohistochemical and molecular tests.

An essential component of this course is the in-depth exploration of prognostic and predictive assays in breast cancer patients. Our faculty will discuss these assays, providing you with the necessary knowledge to interpret them accurately and apply the results to guide treatment decisions.

By participating in this educational initiative, you will achieve a range of learning objectives. Firstly, you will develop an in-depth understanding of the diagnostic criteria and clinical significance associated with a diverse array of benign, in situ, and malignant breast lesions. This knowledge will empower you to make precise diagnoses and contribute to optimal patient care.

Secondly, you will enhance your proficiency in differential diagnosis. Engage in discussions about common diagnostic challenges in breast pathology and learn how to utilize immunohistochemical and molecular assays to resolve these challenges effectively.

Lastly, you will gain insights into patient management through the exploration of prognostic and predictive assays. These assays play a crucial role in guiding treatment decisions, and by mastering their interpretation, you will have a significant impact on patient outcomes.

Our distinguished faculty members, consisting of leading experts in the field, will cover a range of topics, including lobular, mucinous, and fibroepithelial lesions, lumpectomy margin evaluation, papillary lesions, neoadjuvant chemotherapy, and many more. We have also included a session on hot and controversial topics in breast pathology to keep you up to date with the latest developments.

Order now and receive exclusive access to this educational course! By integrating cutting-edge knowledge with practical methodologies, our course equips you with the tools and insights needed to address diagnostic uncertainties and provide the best possible care to breast cancer patients.

Don’t miss out on this valuable opportunity to enhance your expertise in breast pathology. Order your copy of the course today!

Product Details

  • Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
  • Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
  • Discuss prognostic and predictive assays in patients with breast cancer

Related Products